JP5285625B2 - ネコ科動物の免疫系を強化するための組成物及び方法 - Google Patents

ネコ科動物の免疫系を強化するための組成物及び方法 Download PDF

Info

Publication number
JP5285625B2
JP5285625B2 JP2009551045A JP2009551045A JP5285625B2 JP 5285625 B2 JP5285625 B2 JP 5285625B2 JP 2009551045 A JP2009551045 A JP 2009551045A JP 2009551045 A JP2009551045 A JP 2009551045A JP 5285625 B2 JP5285625 B2 JP 5285625B2
Authority
JP
Japan
Prior art keywords
composition
feline
immune response
ppm
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2009551045A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010519315A (ja
JP2010519315A5 (enExample
Inventor
ヤムカ，ライアン・マイケル
フリーセン，キム・ジーン
ズィッカー，スティーヴン・カーティス
Original Assignee
ヒルズ・ペット・ニュートリシャン・インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヒルズ・ペット・ニュートリシャン・インコーポレーテッド filed Critical ヒルズ・ペット・ニュートリシャン・インコーポレーテッド
Publication of JP2010519315A publication Critical patent/JP2010519315A/ja
Publication of JP2010519315A5 publication Critical patent/JP2010519315A5/ja
Application granted granted Critical
Publication of JP5285625B2 publication Critical patent/JP5285625B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2009551045A 2007-02-22 2008-02-22 ネコ科動物の免疫系を強化するための組成物及び方法 Active JP5285625B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89117107P 2007-02-22 2007-02-22
US60/891,171 2007-02-22
PCT/US2008/054789 WO2008103950A1 (en) 2007-02-22 2008-02-22 Compositions and methods for enhancing immune system of felines

Publications (3)

Publication Number Publication Date
JP2010519315A JP2010519315A (ja) 2010-06-03
JP2010519315A5 JP2010519315A5 (enExample) 2010-12-24
JP5285625B2 true JP5285625B2 (ja) 2013-09-11

Family

ID=39563552

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2009551045A Active JP5285625B2 (ja) 2007-02-22 2008-02-22 ネコ科動物の免疫系を強化するための組成物及び方法
JP2009551040A Active JP5474570B2 (ja) 2007-02-22 2008-02-22 成長する動物の発育を促進するための組成物と方法
JP2009551049A Active JP5474571B2 (ja) 2007-02-22 2008-02-22 遺伝子発現を変化させるための組成物および方法
JP2009551043A Expired - Fee Related JP5286286B2 (ja) 2007-02-22 2008-02-22 神経的発達を強化するための組成物と方法
JP2009551047A Expired - Fee Related JP5286287B2 (ja) 2007-02-22 2008-02-22 骨発達を促進するための組成物及び方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2009551040A Active JP5474570B2 (ja) 2007-02-22 2008-02-22 成長する動物の発育を促進するための組成物と方法
JP2009551049A Active JP5474571B2 (ja) 2007-02-22 2008-02-22 遺伝子発現を変化させるための組成物および方法
JP2009551043A Expired - Fee Related JP5286286B2 (ja) 2007-02-22 2008-02-22 神経的発達を強化するための組成物と方法
JP2009551047A Expired - Fee Related JP5286287B2 (ja) 2007-02-22 2008-02-22 骨発達を促進するための組成物及び方法

Country Status (12)

Country Link
US (6) US9888709B2 (enExample)
EP (5) EP2112889B1 (enExample)
JP (5) JP5285625B2 (enExample)
CN (6) CN101662951A (enExample)
AU (5) AU2008218193B2 (enExample)
BR (5) BRPI0807691A2 (enExample)
CA (5) CA2679008C (enExample)
DK (1) DK2129237T3 (enExample)
ES (1) ES2546284T3 (enExample)
RU (5) RU2436410C2 (enExample)
WO (5) WO2008103956A1 (enExample)
ZA (5) ZA200906388B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1937721T1 (sl) * 2005-08-25 2010-11-30 Lilly Co Eli Anti il protitelesa
CA2679008C (en) 2007-02-22 2014-08-12 Ryan Michael Yamka Compositions and methods for promoting bone development
WO2010068173A1 (en) * 2008-12-12 2010-06-17 Daniel Klamer L-lysine for improving normal cognitive functions
JP2013515500A (ja) 2009-12-29 2013-05-09 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 炎症性の病気の改善または予防のための、ショウガが含まれる組成物
RU2012153677A (ru) * 2010-05-12 2014-06-20 Хилл'С Пет Ньютришн, Инк. Способы диагностики, контроля и профилактики воспаления и облегчения воспалительных состояний у кошачьих
EP2654451B1 (en) * 2010-12-20 2016-04-13 Hill's Pet Nutrition, Inc. Pet food compositions for inducing a satiety response
WO2012141316A1 (ja) * 2011-04-13 2012-10-18 味の素株式会社 栄養組成物
US8828426B2 (en) 2011-06-07 2014-09-09 Zx Pharma, Llc Multiparticulate L-carnitine compositions and related methods
AU2012355775B2 (en) 2011-12-19 2015-10-08 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating hyperthyroidism in companion animals
CN103315187B (zh) * 2013-07-17 2014-11-05 江苏桂龙生物技术有限公司 一种预防宠物骨骼性疾病的饲料
CN104026401B (zh) * 2014-06-10 2016-04-27 务川县绿之源农业技术推广中心 一种小型幼犬粮
US20170360737A1 (en) * 2014-10-30 2017-12-21 Fuji Oil Holdings Inc. Long-chain polyunsaturated fatty-acid-containing fat and food containing same
GB201522300D0 (en) * 2015-12-17 2016-02-03 Mars Inc Puppy growth food product
ES2953519T3 (es) 2016-12-15 2023-11-14 Nestle Sa Composiciones y métodos que modulan la vitamina D y el contenido mineral óseo en un animal de compañía
EP3554267A1 (en) 2016-12-15 2019-10-23 Société des Produits Nestlé S.A. Compositions and methods for small canines
JP2020521783A (ja) * 2017-05-29 2020-07-27 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 心拡大及び／又は心臓弁膜症の予防又は治療に使用するための中鎖脂肪酸
US20190240180A1 (en) * 2018-02-08 2019-08-08 Nestec Sa Mct-based nutrition blend for providing health benefits in companion animals
CN108244374A (zh) * 2018-02-27 2018-07-06 佛山市雷米高动物营养保健科技有限公司 猫用营养粉剂及其制备方法
EP3917329A4 (en) * 2019-02-01 2022-11-30 Mars, Incorporated CAT FOOD COMPOSITION
CN110537630A (zh) * 2019-09-09 2019-12-06 天津农学院 1，2二硫戊环-3-戊酸的应用、幼犬鲜粮和延长幼犬鲜粮贮藏期的方法
AU2020410289B2 (en) * 2019-12-19 2026-02-05 Societe Des Produits Nestle Sa Compositions and methods for providing a health benefit to a growing animal
US20230165281A1 (en) * 2021-11-29 2023-06-01 Société des Produits Nestlé S.A. Methods and compositions for providing a health benefit in an animal
WO2023150389A1 (en) * 2022-02-07 2023-08-10 Cornell University Compositions and methods for increasing dha availability

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267195A (en) * 1976-09-10 1981-05-12 University Of Texas Dog food flavors
US4130651A (en) * 1978-03-31 1978-12-19 American Cyanamid Company Butamisole injectable formulations having improved margin of safety in dogs
JPH0625057B2 (ja) * 1987-12-14 1994-04-06 日本油脂株式会社 骨形成促進剤
JPH04166039A (ja) * 1990-10-26 1992-06-11 Hirotoshi Yokura ペットフード
US5690988A (en) * 1996-02-02 1997-11-25 Colgate Palmolive Company Pet food composition of improved palatability and a method of enhancing the palatability of a food composition
US5851573A (en) * 1997-04-29 1998-12-22 The Iams Company Pet food composition for large breed puppies and method for promoting proper skeletal growth
US6156355A (en) * 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations
NZ527924A (en) * 1999-01-29 2005-01-28 Mars Uk Ltd Antioxidant compositions and methods for companion animals
GB2367489B (en) * 2000-07-31 2005-02-09 Mars Inc Use of antioxidants
US6071544A (en) * 1999-04-01 2000-06-06 The Iams Company Dietary compositions and method for promoting healthy weight loss cats
NZ514727A (en) * 1999-05-27 2003-10-31 Iams Company Enhancing immune response in pets using vitamin E, lutein and beta-carotene in a pet food product
EG22407A (en) * 2000-02-17 2003-01-29 Iams Company Method for improving bone modeling and chondrocyte functioning in growing canines
GB2367487A (en) 2000-10-04 2002-04-10 John Kennedy Mcmillan Tooth cleaner
DK1345500T3 (da) * 2000-12-29 2008-11-24 Martin Francis Gannon Foderprodukt til dyr
US6582752B2 (en) * 2001-11-02 2003-06-24 Nestec, Ltd Methods and compositions for a gender specific diet for puppies
WO2004006688A1 (en) * 2002-07-12 2004-01-22 The Iams Company Synergistic effect of diet and human interaction on the behavior of dogs
JPWO2004008196A1 (ja) * 2002-07-13 2005-11-10 有限会社オートクローニング・テクノロジー 偏光解析装置
AU2003254544A1 (en) * 2002-07-26 2004-02-23 Dsm Ip Assets B.V. Compositions comprising lactoferrin
US20070082008A1 (en) 2003-03-07 2007-04-12 Advanced Bionutrition Corporation Feed formulation for terrestrial and aquatic animals
US20070037885A1 (en) 2003-04-25 2007-02-15 Sandra Edwards Biomass containing animal feed
JP2007524402A (ja) * 2003-07-03 2007-08-30 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド コンパニオン動物における精神活動の加齢劣化を減少させる組成物及び方法
WO2005006878A1 (en) * 2003-07-07 2005-01-27 Hill's Pet Nutrition, Inc. Compositions for improved oxidative status in companion animals
AU2004210599B2 (en) 2003-09-12 2009-09-24 Mars, Incorporated Food product for hairball treatment
US8921422B2 (en) * 2003-10-01 2014-12-30 The Iams Company Methods and kits for enhancing ability to learn in a puppy or kitten
US20050266051A1 (en) * 2004-05-27 2005-12-01 The Procter & Gamble Company Pet food compositions and methods
JP5543688B2 (ja) * 2004-08-30 2014-07-09 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ゲノムベースのダイエットデザイン
CN1631207A (zh) 2004-12-03 2005-06-29 王志文 能改善猫狗皮毛质量的不饱和脂肪酸饲料添加剂及饲料
CN101150962A (zh) 2004-12-30 2008-03-26 希尔氏宠物营养品公司 提高幼年动物生活质量的方法
AU2005322887B2 (en) * 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
WO2007041418A2 (en) 2005-09-30 2007-04-12 Nestec S.A. Methods and compositions for improving cognitive function
AU2007204692B2 (en) * 2006-01-10 2011-06-02 Hill's Pet Nutrition, Inc. Compositions and method for promoting fat loss
CA2660291C (en) 2006-08-09 2011-11-22 The Iams Company Methods of improving bone health and muscle health
CA2679008C (en) * 2007-02-22 2014-08-12 Ryan Michael Yamka Compositions and methods for promoting bone development

Also Published As

Publication number Publication date
AU2008231241A1 (en) 2008-10-02
CN101686711A (zh) 2010-03-31
CA2679065A1 (en) 2008-10-02
CN101686712A (zh) 2010-03-31
RU2427278C2 (ru) 2011-08-27
EP2112889B1 (en) 2015-11-04
JP2010519317A (ja) 2010-06-03
WO2008103939A1 (en) 2008-08-28
JP2010519315A (ja) 2010-06-03
JP2010518866A (ja) 2010-06-03
CA2679682C (en) 2012-09-11
BRPI0807790A2 (pt) 2014-06-24
US20100143497A1 (en) 2010-06-10
EP2124612B1 (en) 2015-10-21
CA2679008A1 (en) 2008-08-28
CA2679065C (en) 2014-07-08
ES2546284T3 (es) 2015-09-22
CN101662951A (zh) 2010-03-03
AU2008218187B2 (en) 2011-07-07
CA2679215C (en) 2015-11-24
DK2129237T3 (en) 2015-09-14
AU2008218195B2 (en) 2011-11-03
BRPI0807691A2 (pt) 2017-05-02
ZA200908481B (en) 2014-05-28
AU2008218187C1 (en) 2012-02-16
AU2008218176B2 (en) 2011-09-29
CA2678938C (en) 2012-09-18
WO2008118586A1 (en) 2008-10-02
RU2412611C1 (ru) 2011-02-27
CA2679008C (en) 2014-08-12
CN101662950A (zh) 2010-03-03
JP5474570B2 (ja) 2014-04-16
US20100137404A1 (en) 2010-06-03
RU2009135261A (ru) 2011-03-27
CA2678938A1 (en) 2008-08-28
JP5286286B2 (ja) 2013-09-11
RU2435435C2 (ru) 2011-12-10
CN101662949A (zh) 2010-03-03
EP2124611A1 (en) 2009-12-02
RU2009135231A (ru) 2011-03-27
US20110059202A1 (en) 2011-03-10
BRPI0807790B1 (pt) 2017-08-01
CA2679682A1 (en) 2008-08-28
AU2008218193A1 (en) 2008-08-28
CN101662949B (zh) 2013-09-04
US20100104599A1 (en) 2010-04-29
ZA200906389B (en) 2014-03-26
AU2008218176A1 (en) 2008-08-28
RU2441394C2 (ru) 2012-02-10
WO2008103950A1 (en) 2008-08-28
AU2008218195A1 (en) 2008-08-28
RU2009135260A (ru) 2011-03-27
BRPI0807373A2 (pt) 2014-05-06
BRPI0807372A2 (pt) 2014-05-06
ZA200906388B (en) 2014-03-26
EP2129237A1 (en) 2009-12-09
US20100093859A1 (en) 2010-04-15
US20110059138A1 (en) 2011-03-10
RU2009135263A (ru) 2011-03-27
CN101686712B (zh) 2015-07-22
EP2112889A1 (en) 2009-11-04
JP2010518867A (ja) 2010-06-03
AU2008218187A1 (en) 2008-08-28
JP5286287B2 (ja) 2013-09-11
AU2008218193B2 (en) 2011-09-29
US9848622B2 (en) 2017-12-26
CA2679215A1 (en) 2008-08-28
ZA200906390B (en) 2014-08-27
EP2124612A1 (en) 2009-12-02
CN104472871A (zh) 2015-04-01
US9888709B2 (en) 2018-02-13
WO2008103956A1 (en) 2008-08-28
EP2124611B1 (en) 2016-01-13
EP2129237B1 (en) 2015-06-17
AU2008218195C1 (en) 2012-05-24
BRPI0807789A2 (pt) 2014-06-24
AU2008231241B2 (en) 2011-11-10
WO2008103958A1 (en) 2008-08-28
RU2436410C2 (ru) 2011-12-20
JP2010518865A (ja) 2010-06-03
EP2124610A1 (en) 2009-12-02
JP5474571B2 (ja) 2014-04-16
ZA200906387B (en) 2014-03-26

Similar Documents

Publication Publication Date Title
AU2008218187B2 (en) Compositions and methods for enhancing immune system of felines
JP5791520B2 (ja) 動物において肝および免疫機能を向上させるための方法
RU2470522C2 (ru) Воздействие на свиней для уменьшения коэффициента усвоения корма или увеличения темпа роста
JP4911374B2 (ja) リジン含有抗肥満または抗高脂血食品、飼料またはサプリメント
Ruampatana et al. Maternal bis-glycinate bound zinc supplementation alters sow performance and milk metabolomic-lipidomic profiles and mitigates piglet diarrhea

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101105

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101105

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120330

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120629

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120706

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120730

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130502

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130531

R150 Certificate of patent or registration of utility model

Ref document number: 5285625

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250